GLSHQ (Gelesis Holdings) OCF Margin %: 55.74% (As of Jun. 2023)


What is Gelesis Holdings OCF Margin %?

Gelesis Holdings GLSHQ -99.00% OCF Margin % is 55.74% as of Jun. 2023.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Gelesis Holdings's Cash Flow from Operations for the three months ended in Jun. 2023 was $0.62 Mil. Gelesis Holdings's Revenue for the three months ended in Jun. 2023 was $1.11 Mil. Therefore, Gelesis Holdings's OCF Margin % for the quarter that ended in Jun. 2023 was 55.74%.

As of today, Gelesis Holdings's current OCF Yield % is 0.00%.

The historical rank and industry rank for Gelesis Holdings's OCF Margin % or its related term are showing as below:

GLSHQ' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -379.2

GLSHQ's OCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -66.52 vs GLSHQ: -379.20

Gelesis Holdings OCF Margin % Related Terms

Gelesis Holdings OCF Margin % Historical Data

* Premium members only.

The historical data trend for Gelesis Holdings's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelesis Holdings OCF Margin % Chart

Gelesis Holdings Annual Data
Trend Dec21 Dec22
OCF Margin %
-494.33 -301.66

Gelesis Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -51.14 -325.93 -619.29 -496.06 55.74

GLSHQ vs RBSH, PPCB, RGMP: OCF Margin % Comparison

For the Biotechnology subindustry, Gelesis Holdings's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gelesis Holdings OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gelesis Holdings's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Gelesis Holdings's OCF Margin % falls into.


Gelesis Holdings OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Gelesis Holdings's OCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-77.728/25.767
=-301.66 %

Gelesis Holdings's OCF Margin for the quarter that ended in Jun. 2023 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=0.617/1.107
=55.74 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 55.74% mean?
Gelesis Holdings (GLSHQ) has a OCF Margin % of 55.74% as of Jun. 2023. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Gelesis Holdings and its competitors.
Is Gelesis Holdings' OCF Margin % too high?
Gelesis Holdings' current OCF Margin % is 55.74%.
How does Gelesis Holdings' OCF Margin % compare to RBSH and PPCB?
Gelesis Holdings' OCF Margin % of 55.74% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Gelesis Holdings and its competitors. Gelesis Holdings's current OCF Margin % is 55.74%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelesis Holdings stock overvalued right now?
Gelesis Holdings (GLSHQ) has a current OCF Margin % of 55.74%. The current OCF Margin % is 55.74%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Gelesis Holdings (GLSHQ), the current OCF Margin % is 55.74% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelesis Holdings Business Description

Address 501 Boylston Street, Suite 6102, Boston, MA, USA, 02116
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.